Your browser doesn't support javascript.
loading
Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriers.
Eltanameli, Bassma; Piñeiro-Llanes, Janny; Cristofoletti, Rodrigo.
Afiliación
  • Eltanameli B; Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA.
  • Piñeiro-Llanes J; Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Cristofoletti R; Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA.
Expert Opin Drug Metab Toxicol ; 20(6): 439-458, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38850058
ABSTRACT

INTRODUCTION:

Recent years have witnessed remarkable progress in the development of cell-based in vitro models aimed at predicting drug permeability, particularly focusing on replicating the barrier properties of the blood-brain barrier (BBB), intestinal epithelium, and lung epithelium. AREA COVERED This review provides an overview of 2D in vitro platforms, including monocultures and co-culture systems, highlighting their respective advantages and limitations. Additionally, it discusses tools and techniques utilized to overcome these limitations, paving the way for more accurate predictions of drug permeability. Furthermore, this review delves into emerging technologies, particularly microphysiological systems (MPS), encompassing static platforms such as organoids and dynamic platforms like microfluidic devices. Literature searches were performed using PubMed and Google Scholar. We focus on key terms such as in vitro permeability models, MPS, organoids, intestine, BBB, and lungs. EXPERT OPINION The potential of these MPS to mimic physiological conditions more closely offers promising avenues for drug permeability assessment. However, transitioning these advanced models from bench to industry requires rigorous validation against regulatory standards. Thus, there is a pressing need to validate MPS to industry and regulatory agency standards to exploit their potential in drug permeability prediction fully. This review underscores the importance of such validation processes to facilitate the translation of these innovative technologies into routine pharmaceutical practice.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Permeabilidad / Barrera Hematoencefálica / Mucosa Intestinal / Modelos Biológicos Límite: Animals / Humans Idioma: En Revista: Expert Opin Drug Metab Toxicol Asunto de la revista: METABOLISMO / TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Permeabilidad / Barrera Hematoencefálica / Mucosa Intestinal / Modelos Biológicos Límite: Animals / Humans Idioma: En Revista: Expert Opin Drug Metab Toxicol Asunto de la revista: METABOLISMO / TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido